[Supplementary]Efficacy and safety of once‐weekly glucagon‐like peptide 1 receptor agonists for the management of type 2 diabetes: a systematic review and meta‐analysis of randomized controlled trials

Post time 2024-4-20 17:49:33

journal：Diabetes, Obesity and Metabolism

Authors：T. Karagiannis; A. Liakos; E. Bekiari; E. Athanasiadou; P. Paschos; D. Vasilakou; M. Mainou; M. Rika; P. Boura; D. R. Matthews; A. Tsapas

Published date：2015-11-

DOI：10.1111/dom.12541

PDF link：https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12541

Article link：http://dx.doi.org/10.1111/dom.12541

Article Source：Wiley。

Remark：

Post time 2024-4-20 17:49:34

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Wiley] [Supplementary]Efficacy and safety of once‐weekly glucagon‐like peptide 1 receptor agonists for the management of type 2 diabetes: a systematic review and meta‐analysis of randomized controlled trials

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Wiley] [Supplementary]Efficacy and safety of once‐weekly glucagon‐like peptide 1 receptor agonists for the management of type 2 diabetes: a systematic review and meta‐analysis of randomized controlled trials Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Wiley] [Supplementary]Efficacy and safety of once‐weekly glucagon‐like peptide 1 receptor agonists for the management of type 2 diabetes: a systematic review and meta‐analysis of randomized controlled trials